157 related articles for article (PubMed ID: 28744130)
1. Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway.
Wang R; Li Y; Zhu G; Tian B; Zeng W; Yang Y; Li Z
Neuropsychiatr Dis Treat; 2017; 13():1805-1813. PubMed ID: 28744130
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
[TBL] [Abstract][Full Text] [Related]
5. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
6. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
7. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
Yu X; Zheng H; Tse G; Zhang L; Wu WKK
Cell Prolif; 2018 Dec; 51(6):e12506. PubMed ID: 30094876
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA AB073614 promotes the malignance of glioma by activating Wnt/β-catenin signaling through downregulating SOX7.
Li Y; Zhu G; Zeng W; Wang J; Li Z; Wang B; Tian B; Lu D; Zhang X; Gao G; Li L
Oncotarget; 2017 Sep; 8(39):65577-65587. PubMed ID: 29029454
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling.
Wang H; Sheng ZG; Dai LZ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1600-1609. PubMed ID: 30840283
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway.
Gong X; Liao X; Huang M
Pathol Res Pract; 2019 Mar; 215(3):564-570. PubMed ID: 30661904
[TBL] [Abstract][Full Text] [Related]
12. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma.
Xiong X; Zhu H; Chen X
Biomed Pharmacother; 2017 Sep; 93():391-397. PubMed ID: 28654795
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway.
Wang K; Yang S; Gao Y; Zhang C; Sui Q
Oncol Lett; 2020 Jan; 19(1):992-1000. PubMed ID: 31897212
[TBL] [Abstract][Full Text] [Related]
14. The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics.
Yu L; Chen S; Bao H; Zhang W; Liao M; Liang Q; Cheng X
Onco Targets Ther; 2018; 11():4355-4365. PubMed ID: 30100741
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
17. Low Expression of LncRNA Cancer Susceptibility Candidate 2 and its Clinical Significance in Cancer Tissues.
Zhu ZM; Liu FT; Chen X
Cell Physiol Biochem; 2018; 46(4):1643-1649. PubMed ID: 29694965
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway.
Li P; Xue WJ; Feng Y; Mao QS
Am J Transl Res; 2016; 8(8):3522-9. PubMed ID: 27648142
[TBL] [Abstract][Full Text] [Related]
19. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
Zhang D; Guo S; Wang H; Hu Y
Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway.
Fu X; Li H; Liu C; Hu B; Li T; Wang Y
Onco Targets Ther; 2016; 9():3815-27. PubMed ID: 27445486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
